Compared to the placebo, patients treated with Kisunla had a 35% slower cognitive and functional decline at 18 months of ...

Several people in fresno were among the first in the nation to receive a new treatment for alzheimer's disease.Now patients ...

What is the new drug recently approved by the FDA for Alzheimer’s disease? In July, the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) for the treatment of people living ...

FRESNO, Calif. (KFSN) -- A long-time Fresno doctor is part of a ground-breaking treatment in the fight against Alzheimer's.

As quantitative data replaced qualitative descriptions in the ads, and as information about severe adverse effects was ...

Several Alzheimer’s patients in Fresno became some of the first in the nation to receive a new drug just approved by the FDA.

After Eli Lilly received Food and Drug Administration approval for Alzheimer’s drug Kisunla last month, a company exec was quoted as saying the drugmaker “really needs to raise awareness that there ...

Kisunla (donanemab-azbt) is a prescription drug that’s used to treat Alzheimer’s disease in adults. Kisunla is given as an intravenous (IV) infusion by a doctor or other healthcare professional.

The first drug of this kind has been approved for the treatment of Alzheimer’s disease. Donanemab (Kisunla) andlecanemab-irmb (Leqembi). The FDA gave approval to lecanemab-irmb in January 2023.

Kisunla (donanemab-azbt) is a prescription drug that’s used to treat Alzheimer’s disease in adults. This drug currently isn’t known to interact with other drugs. Note: As a person’s ...

Alzheimer’s medications have some common ... They include donanemab (Kisunla) and lecanemab (Leqembi). Monoclonal antibodies are given through an IV. Some people taking lecanemab have bad ...